Vise Technologies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2M Buy
34,353
+10,795
+46% +$11M 0.47% 46
2026
Q1
$25.3M Hold
23,558
0.5% 37
2025
Q4
$25.3M Buy
23,558
+8,121
+53% +$7.77M 0.5% 37
2025
Q3
$11.8M Sell
15,437
-6,319
-29% -$4.7M 0.44% 45
2025
Q2
$17M Buy
+21,756
New +$16.9M 0.7% 21
2024
Q4
$9.18M Buy
11,896
+4,330
+57% +$3.59M 0.77% 23
2024
Q3
$6.7M Buy
7,566
+1,681
+29% +$1.51M 0.85% 22
2024
Q2
$5.33M Buy
5,885
+117
+2% +$93.6K 0.93% 22
2024
Q1
$4.49M Buy
5,768
+916
+19% +$652K 0.88% 24
2023
Q4
$2.83M Buy
4,852
+522
+12% +$305K 0.61% 40
2023
Q3
$2.33M Sell
4,330
-249
-5% -$128K 0.57% 40
2023
Q2
$2.15M Buy
4,579
+752
+20% +$315K 0.52% 42
2023
Q1
$1.31M Buy
3,827
+648
+20% +$219K 0.35% 70
2022
Q4
$1.16M Buy
3,179
+583
+22% +$207K 0.36% 65
2022
Q3
$839K Buy
2,596
+608
+31% +$193K 0.32% 65
2022
Q2
$645K Buy
1,988
+812
+69% +$244K 0.25% 98
2022
Q1
$337K Buy
+1,176
New +$303K 0.13% 155

Other funds holding LLY

Vise Technologies's LLY Position: Q2 2026 in Review

Vise Technologies increased its Eli Lilly (LLY) stake by 46% in Q2 2026, buying an estimated $11M and bringing the position to 34,353 shares worth $41.2M. The position accounts for 0.47% of the portfolio, ranked #46.

Vise Technologies first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vise Technologies held 34,353 shares of Eli Lilly worth $41.2M as of Q2 2026.
  • Vise Technologies bought 10,795 Eli Lilly shares in Q2 2026, an estimated $11M.
  • Eli Lilly made up 0.47% of Vise Technologies's portfolio in Q2 2026, its #46 holding.
  • Vise Technologies first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.